Methanol extract of Elsholtzia fruticosa promotes 3T3-L1 preadipocyte differentiation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Elsholtzia fruticosa (EF) is present in tropical regions throughout South Asian countries as well as the Himalayas. Although it has been used as a traditional medicine to treat digestive, respiratory, and inflammatory issues, its effect on preadipocyte differentiation is unknown. In this study, we examined the effects of a methanol extract prepared from EF on the differentiation of 3T3-L1 preadipocytes. Cell differentiation was assessed by microscopic observation and oil-red O staining. The expression of adipogenic and lipogenic genes, including PPARγ and C/EBPα, was measured by western blot analysis and quantitative real-time polymerase chain reaction (qRT–PCR), to provide insight into adipogenesis and lipogenesis mechanisms. The results indicated that EF promotes the differentiation of 3T3-L1 preadipocytes, with elevated lipid accumulation occurring in a concentration-dependent manner without apparent cytotoxicity. EF enhances the expression of adipogenic and lipogenic genes, including PPARγ, FABP4, adiponectin, and FAS, at the mRNA and protein levels. The effect of EF was more pronounced during the early and middle stages of 3T3-L1 cell differentiation. Treatment with EF decreased C/EBP homologous protein (CHOP) mRNA and protein levels, while increasing C/EBPα and PPARγ expression. Treatment with EF resulted in the upregulation of cyclin E and CDK2 gene expression within 24 h, followed by a decrease at 48 h, demonstrating the early-stage impact of EF. A concomitant increase in cyclin-D1 levels was observed compared with untreated cells, indicating that EF modulates lipogenic and adipogenic genes through intricate mechanisms involving CHOP and cell cycle pathways. In summary, EF induces the differentiation of 3T3-L1 preadipocytes by increasing the expression of adipogenic and lipogenic genes, possibly through CHOP and cell cycle-dependent mechanisms.
Abstract
Elsholtzia fruticosa (EF) is present in tropical regions throughout South Asian countries as well as the Himalayas. Although it has been used as a traditional medicine to treat digestive, respiratory, and inflammatory issues, its effect on preadipocyte differentiation is unknown. In this study, we examined the effects of a methanol extract prepared from EF on the differentiation of 3T3-L1 preadipocytes. Cell differentiation was assessed by microscopic observation and oil-red O staining. The expression of adipogenic and lipogenic genes, including PPARγ and C/EBPα, was measured by western blot analysis and quantitative real-time polymerase chain reaction (qRT–PCR), to provide insight into adipogenesis and lipogenesis mechanisms. The results indicated that EF promotes the differentiation of 3T3-L1 preadipocytes, with elevated lipid accumulation occurring in a concentration-dependent manner without apparent cytotoxicity. EF enhances the expression of adipogenic and lipogenic genes, including PPARγ, FABP4, adiponectin, and FAS, at the mRNA and protein levels. The effect of EF was more pronounced during the early and middle stages of 3T3-L1 cell differentiation. Treatment with EF decreased C/EBP homologous protein (CHOP) mRNA and protein levels, while increasing C/EBPα and PPARγ expression. Treatment with EF resulted in the upregulation of cyclin E and CDK2 gene expression within 24 h, followed by a decrease at 48 h, demonstrating the early-stage impact of EF. A concomitant increase in cyclin-D1 levels was observed compared with untreated cells, indicating that EF modulates lipogenic and adipogenic genes through intricate mechanisms involving CHOP and cell cycle pathways. In summary, EF induces the differentiation of 3T3-L1 preadipocytes by increasing the expression of adipogenic and lipogenic genes, possibly through CHOP and cell cycle-dependent mechanisms.
참고문헌 (53)
- "World obesity atlas 2023" (2023)[URL]
- NCD Risk Factor Collaboration(NCD-RisC), "Trends in adult body-mass index in 200countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants", Lancet, 387, pp.1377~1396 (2016)[DOI]
- Albuquerque D, "Current review of genetics of human obesity : from molecular mechanisms to an evolutionary perspective", Mol Genet Genomics, 290, pp.1191~1221 (2015)[DOI]
- Hruby A, "The epidemiology of obesity : a big picture", PharmacoEconomics, 33, pp.673~689 (2015)[DOI]
- MacLean PS, "Biological control of appetite : a daunting complexity", Obesity, 25, pp.S8~S16 (2017)[DOI]
- Raciti GA, "Specific CpG hypermethylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity", Sci Rep, 7, pp.43526~ (2017)[DOI]
- Ortega FB, "Obesity and cardiovascular disease", Circ Res, 118, pp.1752~1770 (2016)[DOI]
- Gross B, "PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD", Nat Rev Endocrinol, 13, pp.36~49 (2017)[DOI]
- Hecker J, "Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life", BMC Public Health, 22, pp.46~ (2022)[DOI]
- Pati S, "Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management", Cancers, 15, pp.485~ (2023)[DOI]
- Ying T, "The role of adipocyte precursors in development and obesity", Front Endocrinol, 11, pp.613606~ (2021)[DOI]
- Guru A, "Molecular mechanism of down-regulating adipogenic transcription factors in 3T3-L1 adipocyte cells by bioactive anti-adipogenic compounds", Mol Biol Rep, 48, pp.743~761 (2021)[DOI]
- Molani-Gol R, "The anti-obesity effects of resveratrol on the 3T3-L1 adipocytes", Int J Vitam Nutr Res (2023)[DOI]
- Kusminski CM, "Targeting adipose tissue in the treatment of obesityassociated diabetes", Nat Rev Drug Discov, 15, pp.639~660 (2016)[DOI]
- Wen X, "Signaling pathways in obesity : mechanisms and therapeutic interventions", Signal Transduct Target Ther, 7, pp.298~ (2022)[DOI]
- Aware CB, "Natural bioactive products as promising therapeutics : a review of natural product-based drug development", S Afr J Bot, 151, pp.512~528 (2022)[DOI]
- Naik SR, "Studies in natural products chemistry: bioactive natural products", pp.431~466 (2013), Elsevier
- Imran M, "Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of cancer", Molecules, 28, pp.3475~ (2023)[DOI]
- Thomas I, "Metformin; a review of its history and future : from lilac to longevity", Pediatr Diabetes, 18, pp.10~16 (2017)[DOI]
- Lunagariya NA, "Inhibitors of pancreatic lipase : state of the art and clinical perspectives", EXCLI J, 13, pp.897~921 (2014)
- Park KS, "Raspberry ketone, a naturally occurring phenolic compound, inhibits adipogenic and lipogenic gene expression in 3T3-L1 adipocytes", Pharm Biol, 53, pp.870~875 (2015)[DOI]
- Feng S, "Potential of natural products in the inhibition of adipogenesis through regulation of PPARγ expression and", or its transcriptional activity, 2016, pp.21, 1278~
- Li B, "A large-scale chloroplast phylogeny of the Lamiaceae sheds new light on its subfamilial classification", Sci Rep, 6, pp.34343~ (2016)[DOI]
- Pradhan S, "Essential oils from six aromatic plants of langtang national park : insights on their chemical constituents via GC-MS analysis", Separations, 10, pp.52~ (2023)[DOI]
- Yu X, "The complete chloroplast genome of Elsholtzia fruticosa(D. Don)Rehd. (Labiatae), an ornamental plant with high medicinal value", Mitochondrial DNA B Resour, 8, pp.336~341 (2023)[DOI]
- Taylor RS, "Screening of selected medicinal plants of Nepal for antimicrobial activities", J Ethnopharmacol, 46, pp.153~159 (1995)[DOI]
- Saini R, "Comparison of the volatile constituents of Elsholtzia fruiticosa extracted by hydrodistillation, supercritical fluid extraction and head space analysis", Nat Prod Commun, 5, pp.641~644 (2010)[DOI]
- Kang SH, "Research progress on essential oils and pharmacology of Elsholtzia in China", J Northwest Minzu Univ(Nat Sci), 33, pp.58~63 (2012)
- Liang J, "Chemical composition and biological activity of essential oil extracted from the aerial part of Elsholtzia fruticosa against Ditylenchus destructor", J Essent Oil Bear Plants, 23, pp.575~582 (2020)[DOI]
- Fusani P, "Composition and biological activity of essential oils from Artemisia roxburghiana Besser and Elsholtzia fruticosa Rehder cultivated in Italy", Ind Crops Prod, 187, pp.115317~ (2022)[DOI]
- Eom J, "SLC3A2 and SLC7A2 mediate the exogenous putrescine-induced adipocyte differentiation", Mol Cells, 45, pp.963~975 (2022)[DOI]
- Shrestha J, "Protective effect of Cudrania tricuspidata extract against high-fat diet induced nonalcoholic fatty liver disease through Nrf-2", HO-1 pathway, 2021, pp.26, 2434~
- Moreno-Navarrete JM, "Adipose tissue biology", pp.69~90 (2017), Springer
- Chang E, "Natural products and obesity : a focus on the regulation of mitotic clonal expansion during adipogenesis", Molecules, 24, pp.1157~ (2019)[DOI]
- Shin MC, "Kctd17-mediated Chop degradation promotes adipogenic differentiation", Biochem Biophys Res Commun, 653, pp.126~132 (2023)[DOI]
- Audano M, "Regulatory mechanisms of the early phase of white adipocyte differentiation : an overview", Cell Mol Life Sci, 79, pp.139~ (2022)[DOI]
- Kopp W, "How western diet and lifestyle drive the pandemic of obesity and civilization diseases", Diabetes Metab Syndr Obes, 12, pp.2221~2236 (2019)[DOI]
- Gallagher EJ, "Obesity and diabetes : the increased risk of cancer and cancer-related mortality", Physiol Rev, 95, pp.727~748 (2015)[DOI]
- Karczewski J, "Obesity and the risk of gastrointestinal cancers", Dig Dis Sci, 64, pp.2740~2749 (2019)[DOI]
- Longo M, "Adipose tissue dysfunction as determinant of obesity-associated metabolic complications", Int J Mol Sci, 20, pp.2358~ (2019)[DOI]
- Zatterale F, "Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes", Front Physiol, 10, pp.1607~ (2020)[DOI]
- Jang KO, "Anti-obesity potential of heatkilled Lactiplantibacillus plantarum K8 in 3T3-L1 cells and high-fat diet mice", Heliyon, 9, pp.e12926~ (2023)[DOI]
- Molonia MS, "Low concentrations of antimony impair adipogenesis and endoplasmic reticulum homeostasis during 3T3-L1 cells differentiation", Food Chem Toxicol, 181, pp.114107~ (2023)[DOI]
- Marcelin G, "Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis", J Clin Invest, 129, pp.4032~4040 (2019)[DOI]
- Pham TP, "Berberine exerts anti-adipogenic activity through up-regulation of C", EBP inhibitors, CHOP and DEC2, 2011, pp.413, 376~382
- Ali AT, "Adipocyte and adipogenesis", Eur J Cell Biol, 92, pp.229~236 (2013)[DOI]
- Smith A, "Diazinon exposure activated transcriptional factors CCAAT-enhancerbinding proteins α(C", EBPα)and peroxisome proliferator-activated receptor γ(PPARγ)and induced adipogenesis in 3T3-L1 preadipocytes, 2018, pp.150, 48~58
- Jakab J, "Adipogenesis as a potential anti-obesity target : a review of pharmacological treatment and natural products", Diabetes Metab Syndr Obes, 14, pp.67~83 (2021)[DOI]
- Teixeira C, "Enhanced 3T3-L1 differentiation into adipocytes by pioglitazone pharmacological activation of peroxisome proliferator activated receptor-gamma (PPAR-γ)", Biology, 11, pp.806~ (2022)[DOI]
- Chen R, "Regulation of gadd153 mRNA expression by hypoxia in pulmonary artery smooth muscle cells", Res Commun Mol Pathol Pharmacol, 108, pp.3~14 (2000)
- Hegazi NM, "Headspace gas chromatography", mass spectrometry analysis endorses melaleuca species as abundant source of medicinal eucalyptol and its proposed anti-obesity activity, 2022, pp.65, 607~618
- Liu H, "Eucalyptol relieves the toxicity of diisobutyl phthalate in Ctenopharyngodon idellus kidney cells through Keap1", Nrf2, Fish Shellfish Immunol, pp.2022, 130[DOI]
- Ahmed B, "Adipose tissue and insulin resistance in obese", Biomed Pharmacother, 137, pp.111315~ (2021)[DOI]